ArticleActive
Response to Comments: Transurethral Waterjet Ablation of the Prostate
A58522
Effective: December 27, 2020
Updated: December 31, 2025
Policy Summary
This document (A58522) is a response to public comments about transurethral waterjet ablation of the prostate and does not include specific coverage criteria. It notes that responses address three emphasized issues and mentions an author's observation about preserved sexual function, but provides no actionable indications, limitations, documentation requirements, or frequency limits. Manual review of the underlying meeting record or full policy text is recommended to extract any clinical coverage criteria.